Skip to content
healthcare.dev

Giltuss Bucalsep

NDC 58552-135, Benzocaine, Menthol, Zinc chloride, spray, from Gil Pharmaceutical Corp.

Product NDC
58552-135
Status
Listed
Labeler
Gil Pharmaceutical Corp
Dosage form
SPRAY
Route
ORAL, TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M022
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58552-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENZOCAINE6.5 g/100mL
  • MENTHOL.1 g/100mL
  • ZINC CHLORIDE.12 g/100mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
58552-135-01585520135011 BOTTLE, SPRAY in 1 CARTON (58552-135-01) / 30 mL in 1 BOTTLE, SPRAY

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58552-135 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58552-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58552-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.